[{"NetIncomeLoss_3_Q3_USD":-21784000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":20000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":6056000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-4964000.0,"Depreciation_3_Q3_USD":1100000.0,"Depreciation_1_Q3_USD":399000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":298000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":30.55,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":740250.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q3_shares":195850.0,"AccruedIncomeTaxes_0_Q3_USD":30000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1413000.0,"AssetsCurrent_0_Q3_USD":287652000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q3_USD":4043000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_3_Q3_USD":3205000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":853336.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1385000.0,"CommonStockSharesIssued_0_Q3_shares":19706870.0,"Assets_0_Q3_USD":311451000.0,"ShareBasedCompensation_3_Q3_USD":2702000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":2476000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":117878000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":18477495.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":19676016.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4580000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":10315000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":12264000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":5100000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":39.93,"ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments_3_Q3_USD":5877000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":17187000.0,"CommonStockValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_3_Q3_shares":230745.0,"IncreaseDecreaseInPrepaidRent_3_Q3_USD":2400000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":117878000.0,"PrepaidRent_0_Q3_USD":2400000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q3_USD":286400000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-21774000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":725000.0,"OtherAssetsNoncurrent_0_Q3_USD":1411000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":282369000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2533000.0,"Liabilities_0_Q3_USD":9731000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":10000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-20000.0,"OperatingLeaseLiability_0_Q3_USD":3097000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":11.54,"DepreciationAndAmortization_3_Q3_USD":1361000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-9630000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":895000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1441000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":-489000.0,"VariableLeaseCost_3_Q3_USD":88000.0,"VariableLeaseCost_1_Q3_USD":60000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":104266.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-60831000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":94855000.0,"CommonStockSharesOutstanding_0_Q3_shares":19706870.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":1967000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":21000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":1356000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-18059000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1358000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":853336.0,"LiabilitiesCurrent_0_Q3_USD":7198000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":282369000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":1287000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.08,"AdditionalPaidInCapital_0_Q3_USD":362531000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":76935.0,"NumberOfOperatingSegments_3_Q3_segment":1.0,"PreferredStockSharesIssued_0_Q3_shares":2061773.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":3173000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q3_USD":3285000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":17512000.0,"NetIncomeLoss_1_Q3_USD":-9610000.0,"AccountsPayableCurrent_0_Q3_USD":2591000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":274000.0,"LongTermInvestments_0_Q3_USD":0.0,"StockholdersEquity_0_Q3_USD":301720000.0,"CommonStockSharesAuthorized_0_Q3_shares":80000000.0,"OperatingIncomeLoss_3_Q3_USD":-22579000.0,"OperatingIncomeLoss_1_Q3_USD":-9680000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q3_USD":3996000.0,"GainsLossesOnSalesOfAssets_3_Q3_USD":-33000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_3_Q3_USD":5423000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":46.46,"PreferredStockValue_0_Q3_USD":0.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":9.43,"OperatingLeaseCost_3_Q3_USD":458000.0,"OperatingLeaseCost_1_Q3_USD":148000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":7636000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":311451000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":2702000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":1356000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":19479000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":564000.0,"OperatingExpenses_3_Q3_USD":22579000.0,"OperatingExpenses_1_Q3_USD":9680000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":980000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":0.0,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.49,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.18,"OtherLiabilitiesCurrent_0_Q3_USD":13000.0,"PreferredStockSharesAuthorized_0_Q3_shares":20000000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":358000.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201109"}]